C-peptide is a bioactive peptide

Diabetologia

Volumn 50, Issue 3, 2007, Pages 503-509

  Wahren, J ^a   Ekberg, K ^a   Jornvall H ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Endothelial nitric oxide synthase; G protein; Glomerular filtration rate; Insulin disaggregation; Membrane binding; Microalbuminuria; Na+ K + ATPase; Nerve conduction velocity; Red blood cell deformability

Indexed keywords

C PEPTIDE; INSULIN; PLACEBO;

BINDING AFFINITY; CELL ACTIVITY; CELL MEMBRANE; CLINICAL TRIAL; DIABETIC NEUROPATHY; GLOMERULUS FILTRATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INSULIN TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; MODELS, BIOLOGICAL;

EID: 33846847381     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0559-y     Document Type: Review

References (47)

1. Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert A, Persson A, Östman J (1987) Residual insulin production, glycemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:208-213
2. Zerbini G, Mangili R, Luzi L (1999) Higher post-absorptive C-peptide levels in type 1 diabetic patients without renal complications. Diabet Med 16:1048-1049
3. Navarro X, Sutherland D, Kennedy W (1997) Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 42:727-736
4. Fiorina P, Folli F, Zerbini G et al (2003) Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 14:2150-2158
5. Johansson B-L, Sjöberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in Type I (insulin-dependent) diabetic patients. Diabetologia 35:121-128
6. Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J (2000) Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes. Diabet Med 17:181-189
7. Sjöquist M, Huang W, Johansson B-L (1998) Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54:758-764
8. Samnegård B, Jacobson S, Johansson B-L et al (2005) C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20:532-538
9. Ekberg K, Brismar T, Johansson B-L, Jonsson B, Lindström P, Wahren J (2003) Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536-541
10. Ekberg K, Brismar T, Johansson B-L et al (2007) C-peptide replacement therapy and sensory nerve function in type 1 diabetes neuropathy. Diabetes Care 30:71-76
11. Johansson B-L, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J (1996) C-peptide improves autonomic nerve function IDDM patients. Diabetologia 39:687-695
12. Sima AA, Zhang W, Sugimoto K et al (2001) C-peptide prevents and improves chronic type 1 diabetic polyneuropathy in the BB/Wor rat. Diabetologia 44:889-897
13. Cotter M, Ekberg K, Wahren J, Cameron N (2003) Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Diabetes 52:1812-1817
14. Kamiya H, Zhang W, Sima AA (2004) C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 56:827-835
15. Pierson C, Zhang W, Sima A (2003) Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 62:765-779
16. Johansson B-L, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of Type I (insulin-dependent) diabetic patients. Diabetologia 35:1151-1158
17. Johansson B-L, Sundell J, Ekberg K et al (2004) C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. Am J Physiol Endocrinol Metab 286:E14-E19
18. Hansen A, Johansson B-L, Wahren J, von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077-3082
19. Forst T, Kunt T, Pohlmann T et al (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus. J Clin Invest 101:2036-2041
20. Stevens M, Zhang W, Li F, Sima A (2004) C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab 287:E497-E505
21. Lindenblatt N, Braun B, Menger M, Klar E, Vollmar B (2006) C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice. Diabetologia 49:792-800
22. Rigler R, Pramanik A, Jonasson P et al (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96:13318-13323
23. Henriksson M, Pramanik A, Shafqat J et al (2001) Specific binding of proinsulin C-peptide to detergent-solubilised human skin fibroblasts. Biochem Biophys Res Commun 280:423-427
24. Henriksson M, Shafqat J, Liepinsh E et al (2000) Unordered structure of proinsulin C-peptide in aqueous solution and in the presence of lipid vesicles. Cell Mol Life Sci 57:337-342
25. +-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci 61:2782-2790
26. Zhong Z, Davidescu A, Ehrén I et al (2005) C-peptide stimulates ERK1/2 and JNK MAP-kinases via activation of PKC in human renal tubular cells. Diabetologia 48:187-197
27. 2+ increases in human renal tubular cells. Cell Mol Life Sci 59:1185-1189
28. Al-Rasheed N, Meakin F, Royal E et al (2004) Potent activation of multiple signalling pathways by C-peptide in oppossum kidney proximal tubular cells. Diabetologia 47:987-997
29. αi to protect against TNF-α-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 17:986-995
30. Wallerath T, Kunt T, Forst T et al (2003) Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9:95-102
31. Tsimaratos M, Roger F, Chabardès D et al (2003) C-peptide stimulates Na,K-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 46:124-131
32. Grunberger G, Qiang X, Li Z et al (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44:1247-1257
33. Kitamura T, Kimura K, Makondo K et al (2003) Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 46:1698-1705
34. Scalia R, Coyle K, Levine B, Booth G, Lefer A (2000) C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during endothelial dysfunction. FASEB J 14:2357-2364
35. Joshua I, Zhang Q, Falcone J, Bratcher A, Rodriguez W, Tyagi S (2005) Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem 96:1149-1156
36. Chibalin A, Zhong Z, Kotova O, Ehrén I, Ekberg K, Wahren J (2006) Physiological concentrations of C-peptide increase Na,KATPase expression via PKC- and MAP kinase dependent activation of transcription factor ZEB in human renal tubular cells. Diabetologia 49(Suppl 1):A348
37. Ido Y, Vindigni A, Chang K et al (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563-566
38. +ATPase activity in diabetes mellitus type 1. Clin Sci (Lond) 98:283-290
39. Kunt T, Schneider S, Pfützner A et al (1999) The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus. Diabetologia 42:465-471
40. Li Z, Zhang W, Sima A (2003) C-peptide enhances insulin-mediated cell growth and protection against high glucoseinduced apoptosis in SH-SY5Y cells. Diabetes/Metab Res Rev 19:375-385
41. Shafqat J, Melles E, Sigmundson K et al (2006) Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci 63:1805-1811
42. Henriksson M, Nordling E, Melles E et al (2005) Separate functional features of proinsulin C-peptide. Cell Mol Life Sci 62:1772-1778
43. DCCT Group (1995) Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol 38:869-880
44. Sima AA, Nathaniel V, Bril V, McEwen T, Green D (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81:349-364
45. Sima AA (2004) Diabetic neuropathy in type 1 and 2 diabetes and the effect of C-peptide. J Neurol Sci 220:133-136
46. Sima A, Zhang W, Li Z, Murakawa Y, Pierson C (2004) Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. Diabetes 53:1556-1563
47. Luzi L, Zerbini G, Caumo A (2007) C-peptide: a redundant relative of insulin? Diabetologia. doi: 10.1007/s00125-006-0576-x